Zacks Investment Research on MSN
VTRS Q2 earnings beat, revenues rise 5% as Greater China sales jump
Viatris VTRS delivered second-quarter 2026 adjusted earnings per share of 69 cents, which beat the Zacks Consensus Estimate ...
Semaglutide is an injectable drug formulated for the treatment of type 2 diabetes, but it’s since become increasingly popular ...
Treatment should begin as soon as possible, within 72 hours following contact with an individual who has COVID-19. Xocova ® (ensitrelvir) is now available for postexposure prophylaxis (PEP) of ...
Sarah is an experienced writer and editor enthusiastic about helping readers live their healthiest and happiest lives. Before joining Forbes Health, Sarah worked as a writer for various digital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results